In patients with CLL, immune checkpoints such as T-cell immunoglobulin-3 (TIM-3), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and programmed death-1 (PD-1) are upregulated [6,7]. The gene discussed is PDCD1; the disease is B-cell chronic lymphocytic leukemia.